CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75.2% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

Trade Eli Lilly LLY

EliLilly live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

EliLilly news

Emma Rose 2025 Jul 03, 08:35

US Economy on Stagflation Watch: Apollo Global Management's Outlook

Ava Grace 2025 Jul 03, 08:35

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Sophia Claire 2025 Jul 03, 07:35

S&P 500 Earnings Season to Test Rally Amidst Dim Outlook

Sophia Claire 2025 Jul 03, 07:35

AI Podcast: Stock Market Melt-Up Potential? Examining the Bull Run

Noah Lee 2025 Jul 03, 07:35

AI Podcast: Does the Gold-Platinum Ratio Signal Stock Market Risk?

Latest news

Show more

Info

Spread

4.99

Spread (%)

0.6561 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Friday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

692827783168

Shares Outstanding

897736000

Earnings Date (Next)

1997-10-16

Div Yield

2025-09-10

Ex-Dividend Date

2025-08-15

Forward annual dividend rate

6

Forward annual dividend yield

0.0077

EPS

12.31

Learn more about this instrument

Eli Lilly Eli Lilly and Company
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; Verge Genomics; collaboration with AdvanCell to advance novel targeted alpha therapies for the treatment of cancer; and Chugai Pharmaceutical Co., Ltd. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Related Instruments

Asset
Sell
Buy
Change (%)
View all instruments

Latest Education Articles

Show more
Ghko B 2025 Jul 16, 16:00

ASML Stock Slides 11%: Why ASML Stock Is Falling Today?

Stocks
Ghko B 2025 Jul 16, 16:00

XRP Price Hits 6-Month High: How to Trade XRP CFDs with markets.com

Crypto CFD Trading
Frances Wang 2025 Jul 16, 16:00

AI Stock CFD Trading: NVDA Stock CFD, AMZN Stock CFD, ASML Stock CFD

Trustpilot